Evidence map›Paper›PMID 11452004›Full record

ArticleMolecular biology of the cell2001

AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes.

M Huizing, R Sarangarajan, E Strovel, Y Zhao, W A Gahl, R E Boissy

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 153 citations in OpenAlex.

  1. Oncogenic Gα signaling requires AP-3-dependent recruitment to the endolysosomal compartment.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Lysosome-related organelles orchestrate guanine crystal formation in pigment cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Amorphigenin fromCurrent issues in molecular biology · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Melanosome Biogenesis in the Pigmentation of Mammalian Skin.Integrative and comparative biology · 2021
    Review
  16. Article
  17. AP-3-dependent targeting of flippase ATP8A1 to lamellar bodies suppresses activation of YAP in alveolar epithelial type 2 cells.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Review
  19. Coatopathies: Genetic Disorders of Protein Coats.Annual review of cell and developmental biology · 2019
    Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M HuizingSection on Human Biochemical Genetics, Heritable Disorders Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.
R Sarangarajan
E Strovel
Y Zhao
W A Gahl
R E Boissy
National Institutes of Health · USUniversity of Cincinnati · US

Funding

ON THE ROLE OF THE HPS GENE PRODUCT IN MELANOCYTESR01AR045429 · NIAMS · UNIVERSITY OF CINCINNATI · PI BOISSY, RAYMOND E · 1999 to 2002
$629k
HUMAN BIOCHEMICAL GENETICSZ01HD000131 · NICHD · CHILD HEALTH AND HUMAN DEVELOPMENT · PI GAHL, WILLIAM ALLEN · 1985 to 2002
–
NIAMS NIH HHS AR-45429NIAMS NIH HHS R01 AR045429
6 · The paper itself

Abstract

Patients with Hermansky-Pudlak syndrome type 2 (HPS-2) have mutations in the beta 3A subunit of adaptor complex-3 (AP-3) and functional deficiency of this complex. AP-3 serves as a coat protein in the formation of new vesicles, including, apparently, the platelet's dense body and the melanocyte's melanosome. We used HPS-2 melanocytes in culture to determine the role of AP-3 in the trafficking of the melanogenic proteins tyrosinase and tyrosinase-related protein-1 (TRP-1). TRP-1 displayed a typical melanosomal pattern in both normal and HPS-2 melanocytes. In contrast, tyrosinase exhibited a melanosomal (i.e., perinuclear and dendritic) pattern in normal cells but only a perinuclear pattern in the HPS-2 melanocytes. In addition, tyrosinase exhibited a normal pattern of expression in HPS-2 melanocytes transfected with a cDNA encoding the beta 3A subunit of the AP-3 complex. This suggests a role for AP-3 in the normal trafficking of tyrosinase to premelanosomes, consistent with the presence of a dileucine recognition signal in the C-terminal portion of the tyrosinase molecule. In the AP-3-deficient cells, tyrosinase was also present in structures resembling late endosomes or multivesicular bodies; these vesicles contained exvaginations devoid of tyrosinase. This suggests that, under normal circumstances, AP-3 may act on multivesicular bodies to form tyrosinase-containing vesicles destined to fuse with premelanosomes. Finally, our studies demonstrate that tyrosinase and TRP-1 use different mechanisms to reach their premelanosomal destination.

Indexed as

Membrane GlycoproteinsMonomeric Clathrin Assembly ProteinsOxidoreductasesAdaptor Proteins, Vesicular TransportAntigens, CDBiological TransportCarrier ProteinsCell LineHermanski-Pudlak SyndromeHumansMelanocytesMembrane ProteinsMonophenol MonooxygenasePlatelet Membrane GlycoproteinsProteinsTetraspanin 30Adaptor Proteins, Vesicular TransportAntigens, CDCarrier ProteinsCD63 protein, humanclathrin assembly protein AP180Membrane GlycoproteinsMembrane ProteinsMonomeric Clathrin Assembly ProteinsMonophenol MonooxygenaseOxidoreductasesPlatelet Membrane GlycoproteinsProteinsTetraspanin 30tyrosinase-related protein-1TYRP1 protein, human

Identifiers

PMID11452004
PMCPMC55657
OpenAlexW2170832451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.